Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Tang Capital Management LLC reported a 7.00% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Tang Capital Management LLC reported a 7.00% stake in Cytomx Therapeutics, Inc., 11,065,662 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 7.00%
- Shares
- 11,065,662
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 7.00% | 11,065,662 |
| KEVIN TANG | 7.00% | 11,065,662 |
| TANG CAPITAL PARTNERS, LP | 4.70% | 7,409,997 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 2.30% | 3,655,665 |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 |
Source
Related
- Cytomx Therapeutics, Inc.
- Tang Capital Management LLC
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · Tang Capital Management LLC · Feb 17, 2026
- Schedule 13G/A · Tang Capital Management LLC · May 15, 2025
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026